| Financial Year |
March 31 2023 |
| Monetary Funds |
2,859,219,276.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,314,366.81 |
| Accounts Receivable |
2,539,051,634.04 |
| Advances to Suppliers |
549,221,237.85 |
| Other Receivables |
262,268,877.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,278,672,103.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,488,268.52 |
| Total Current Assets |
11,531,218,816.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
950,467.72 |
| Investment Properties |
-- |
| Fixed Assetes |
4,524,701,302.82 |
| Under-construction Projects |
1,209,130,960.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
483,303,920.69 |
| R&D expenses |
-- |
| Goodwill |
762,840,480.04 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
158,671,994.48 |
| Other Non-Current Assets |
234,734,693.27 |
| Sub-Total of Non-Current Assets |
7,521,122,941.63 |
| Total Assets |
19,052,341,757.74 |
| Short-Term Loans |
5,350,936,440.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
106,990,449.42 |
| Accounts Payable |
1,182,157,859.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,613,918.58 |
| Taxes Payable |
77,137,149.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
535,756,711.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
857,416,782.91 |
| Other Current Liabilities |
22,341,829.04 |
| Sub-Total of Current Liabilities |
8,400,780,151.74 |
| Long-term Loans |
2,440,071,909.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
149,207,886.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
50,661,829.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,775,033,618.22 |
| Total Liabilities |
11,175,813,769.96 |
| Paid-In Capital(Or Share Stock) |
506,841,212.00 |
| Capital Surplus |
3,136,838,174.82 |
| Surplus Reserve |
169,663,684.70 |
| LESS:Treasury Stock |
3,713,661.00 |
| Undistributed Profits |
2,166,550,310.43 |
| Minority Stockholder's Interest |
1,905,625,353.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,970,902,634.10 |
| Owner's Equity（Stockholder's Equity） |
7,876,527,987.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,052,341,757.74 |
